Sponsor content
866 result(s) found, displaying 261 to 270
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISOCIP isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISOCIPRALINE isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISOCIP isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29-07-2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29-07-2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29-07-2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29-07-2023
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd